High prevalence and undertreatment of hypercholesterolaemia in participants in a public stroke prevention programme in austria.

Bernhard Iglseder; Titus Moroder; Wolfgang Staffen; Gunther Ladurner

doi:10.2165/00044011-200525110-00004

High prevalence and undertreatment of hypercholesterolaemia in participants in a public stroke prevention programme in austria.

Bernhard Iglseder^* (Erstautor/-in)
, Titus Moroder
, Wolfgang Staffen (Co-Autor/-in)
, Gunther Ladurner

^*Korrespondierende/r Autor/-in für diese Arbeit

Universitätsklinik für Neurologie, neurologische Intensivmedizin und Neurorehabilitation

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

8 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	709-717
Fachzeitschrift	CLINICAL DRUG INVESTIGATION
Jahrgang	25
Ausgabenummer	11
DOIs	https://doi.org/10.2165/00044011-200525110-00004
Publikationsstatus	Veröffentlicht - 2005

Zugriff auf Dokument

10.2165/00044011-200525110-00004

Dieses zitieren

@article{e8571b77b2ab489fbbd8107a4ebc77d4,

title = "High prevalence and undertreatment of hypercholesterolaemia in participants in a public stroke prevention programme in austria.",

keywords = "CORONARY-HEART-DISEASE, SERUM-CHOLESTEROL CONCENTRATION, COST-EFFECTIVENESS, CONTROLLED-TRIAL, RISK, PRAVASTATIN, ATHEROSCLEROSIS, EVENTS, DYSLIPIDEMIA, SIMVASTATIN",

author = "Bernhard Iglseder and Titus Moroder and Wolfgang Staffen and Gunther Ladurner",

note = "Paracelsus Private Med Univ Salzburg, A-5020 Salzburg, Austria",

year = "2005",

doi = "10.2165/00044011-200525110-00004",

language = "English",

volume = "25",

pages = "709--717",

journal = "CLINICAL DRUG INVESTIGATION",

issn = "1173-2563",

number = "11",

}

TY - JOUR

T1 - High prevalence and undertreatment of hypercholesterolaemia in participants in a public stroke prevention programme in austria.

AU - Iglseder, Bernhard

AU - Moroder, Titus

AU - Staffen, Wolfgang

AU - Ladurner, Gunther

N1 - Paracelsus Private Med Univ Salzburg, A-5020 Salzburg, Austria

PY - 2005

Y1 - 2005

KW - CORONARY-HEART-DISEASE

KW - SERUM-CHOLESTEROL CONCENTRATION

KW - COST-EFFECTIVENESS

KW - CONTROLLED-TRIAL

KW - RISK

KW - PRAVASTATIN

KW - ATHEROSCLEROSIS

KW - EVENTS

KW - DYSLIPIDEMIA

KW - SIMVASTATIN

U2 - 10.2165/00044011-200525110-00004

DO - 10.2165/00044011-200525110-00004

M3 - Original Article

C2 - 17532717

SN - 1173-2563

VL - 25

SP - 709

EP - 717

JO - CLINICAL DRUG INVESTIGATION

JF - CLINICAL DRUG INVESTIGATION

IS - 11

ER -